Felipe Couñago: A Timely and Inspiring Contribution to Neuro-Oncology
Felipe Couñago, National Clinical Director at GenesisCare, shared a post on LinkedIn:
“Congratulations to Castalia Fernandez, Pascual Raquel Ciérvide, Ana Aurora Díaz Gavela, and Isabel Garrido Botella for their excellent review just published in Biomedicines:
Radiotherapy in Glioblastoma Multiforme: Evolution, Limitations, and Molecularly Guided Future
This comprehensive work explores:
- The evolution of radiotherapy in GBM, from conventional techniques to IMRT/VMAT
- The impact of the Stupp protocol and Tumor Treating Fields (TTFields) on survival
- Key molecular drivers of radioresistance and tumor recurrence
- The promise of advanced imaging, theranostics, proton/carbon ion therapy, BNCT
- The role of AI in treatment personalization and response assessment
The article highlights both the achievements and limitations of current strategies, while pointing towards a future of precision radiotherapy guided by molecular and imaging biomarkers.
A timely and inspiring contribution to the field of neuro-oncology.”
Title: Radiotherapy in Glioblastoma Multiforme: Evolution, Limitations, and Molecularly Guided Future
Journal: Biomedicines
Authors: Castalia Fernández, Raquel Ciérvide, Ana Díaz, Isabel Garrido, Felipe Couñago
More posts featuring Felipe Couñago on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023